Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1871


The long-term prognosis of Alcoholic Hepatitis is poor and independent of disease severity for patients surviving an acute episode (Reply).

Forrest EH, Atkinson SR, Richardson P, Masson S, Ryder S, Thursz MR, Allison M; STOPAH Trial Management Group.

J Hepatol. 2018 Mar 7. pii: S0168-8278(18)30145-4. doi: 10.1016/j.jhep.2018.02.023. [Epub ahead of print] No abstract available.


Histone deacetylase (HDAC) inhibitor ACY241 enhances anti-tumor activities of antigen-specific central memory cytotoxic T lymphocytes against multiple myeloma and solid tumors.

Bae J, Hideshima T, Tai YT, Song Y, Richardson P, Raje N, Munshi NC, Anderson KC.

Leukemia. 2018 Feb 22. doi: 10.1038/s41375-018-0062-8. [Epub ahead of print]


Genetic Variation of the Kinases that Phosphorylate Tenofovir and Emtricitabine in Peripheral Blood Mononuclear Cells.

Figueroa D, Madeen E, Tillotson J, Richardson P, Cottle L, McCauley M, Landovitz R, Andrade A, Hendrix CW, Mayer KH, Wilkin TJ, Gulick R, Bumpus NN.

AIDS Res Hum Retroviruses. 2018 Feb 17. doi: 10.1089/AID.2017.0243. [Epub ahead of print]


Ibrutinib alone or with dexamethasone for relapsed or relapsed and refractory multiple myeloma: phase 2 trial results.

Richardson PG, Bensinger WI, Huff CA, Costello CL, Lendvai N, Berdeja JG, Anderson LD Jr., Siegel DS, Lebovic D, Jagannath S, Laubach JP, Stockerl-Goldstein KE, Kwei L, Clow F, Elias L, Salman Z, Graef T, Bilotti E, Vij R.

Br J Haematol. 2018 Mar;180(6):821-830. doi: 10.1111/bjh.15058. Epub 2018 Feb 13.


Safety of live-attenuated measles-mumps-rubella and herpes zoster vaccination in multiple myeloma patients on maintenance lenalidomide or bortezomib after autologous hematopoietic cell transplantation.

Pandit A, Leblebjian H, Hammond SP, Laubach JP, Richardson PG, Baden LR, Marty FM, Issa NC.

Bone Marrow Transplant. 2018 Feb 9. doi: 10.1038/s41409-018-0112-x. [Epub ahead of print]


Impact of Fc gamma receptor polymorphisms on efficacy and safety of daratumumab in relapsed/refractory multiple myeloma.

van de Donk NWCJ, Casneuf T, Di Cara A, Parren PW, Zweegman S, van Kessel B, Lokhorst HM, Usmani SZ, Lonial S, Richardson PG, Chiu C, Mutis T, Nijhof IS, Sasser AK.

Br J Haematol. 2018 Feb 7. doi: 10.1111/bjh.15122. [Epub ahead of print] No abstract available.


Positive Predictive Value of International Classification of Diseases, 10th Revision, Codes for Cirrhosis and Its Related Complications.

Mapakshi S, Kramer JR, Richardson P, El-Serag HB, Kanwal F.

Clin Gastroenterol Hepatol. 2018 Feb 1. pii: S1542-3565(18)30113-7. doi: 10.1016/j.cgh.2018.01.042. [Epub ahead of print] No abstract available.


Ixazomib-induced cutaneous necrotizing vasculitis.

Alloo A, Khosravi H, Granter SR, Jadeja SM, Richardson PG, Castillo JJ, LeBoeuf NR.

Support Care Cancer. 2018 Feb 1. doi: 10.1007/s00520-018-4052-1. [Epub ahead of print]


A platform for automated nanomole-scale reaction screening and micromole-scale synthesis in flow.

Perera D, Tucker JW, Brahmbhatt S, Helal CJ, Chong A, Farrell W, Richardson P, Sach NW.

Science. 2018 Jan 26;359(6374):429-434. doi: 10.1126/science.aap9112.


Exploration of the Smallest Diameter Tin Nanowires Achievable with Electrodeposition: Sub 7 nm Sn Nanowires Produced by Electrodeposition from a Supercritical Fluid.

Bartlett PN, Beanland R, Burt J, Hasan MM, Hector AL, Kashtiban RJ, Levason W, Lodge AW, Marks S, Naik J, Rind A, Reid G, Richardson PW, Sloan J, Smith DC.

Nano Lett. 2018 Feb 14;18(2):941-947. doi: 10.1021/acs.nanolett.7b04330. Epub 2018 Feb 2.


Reply to: "Reply to: 'Response to DAA therapy in the NHS England Early Access Programme for rare HCV subtypes from low and middle income countries'".

da Silva Filipe A, Sreenu V, Hughes J, Aranday-Cortes E, Irving WL, Foster GR, Agarwal K, Rosenberg W, Macdonald D, Richardson P, Aldersley MA, Wiselka M, Ustianowski A, McLauchlan J, Thomson EC.

J Hepatol. 2018 Jan 12. pii: S0168-8278(18)30014-X. doi: 10.1016/j.jhep.2017.11.044. [Epub ahead of print] No abstract available.


Evaluating screening approaches for hepatocellular carcinoma in a cohort of HCV related cirrhosis patients from the Veteran's Affairs Health Care System.

Tayob N, Richardson P, White DL, Yu X, Davila JA, Kanwal F, Feng Z, El-Serag HB.

BMC Med Res Methodol. 2018 Jan 4;18(1):1. doi: 10.1186/s12874-017-0458-6.


Defibrotide sodium for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome.

Richardson PG, Triplett BM, Ho VT, Chao N, Dignan FL, Maglio M, Mohty M.

Expert Rev Clin Pharmacol. 2018 Feb;11(2):113-124. doi: 10.1080/17512433.2018.1421943. Epub 2018 Jan 5. Review.


Optimizing therapy for del(17p) multiple myeloma.

Avet-Loiseau H, Richardson PG, di Bacco A.

Oncotarget. 2017 Dec 6;8(66):109859-109860. doi: 10.18632/oncotarget.22987. eCollection 2017 Dec 15. No abstract available.


Intraneural Injection of ATP Stimulates Regeneration of Primary Sensory Axons in the Spinal Cord.

Wu D, Lee S, Luo J, Xia H, Gushchina S, Richardson PM, Yeh J, Krügel U, Franke H, Zhang Y, Bo X.

J Neurosci. 2018 Feb 7;38(6):1351-1365. doi: 10.1523/JNEUROSCI.1660-17.2017. Epub 2017 Dec 26.


Isatuximab plus pomalidomide/dexamethasone versus pomalidomide/dexamethasone in relapsed/refractory multiple myeloma: ICARIA Phase III study design.

Richardson PG, Attal M, Campana F, Le-Guennec S, Hui AM, Risse ML, Corzo K, Anderson KC.

Future Oncol. 2017 Dec 22. doi: 10.2217/fon-2017-0616. [Epub ahead of print]


Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond.

Chim CS, Kumar SK, Orlowski RZ, Cook G, Richardson PG, Gertz MA, Giralt S, Mateos MV, Leleu X, Anderson KC.

Leukemia. 2018 Feb;32(2):252-262. doi: 10.1038/leu.2017.329. Epub 2017 Nov 16. Review.


The proteasome and proteasome inhibitors in multiple myeloma.

Gandolfi S, Laubach JP, Hideshima T, Chauhan D, Anderson KC, Richardson PG.

Cancer Metastasis Rev. 2017 Dec;36(4):561-584. doi: 10.1007/s10555-017-9707-8.


A simple hand-held magnet array for efficient and reproducible SABRE hyperpolarisation using manual sample shaking.

Richardson PM, Jackson S, Parrott AJ, Nordon A, Duckett SB, Halse ME.

Magn Reson Chem. 2017 Nov 28. doi: 10.1002/mrc.4687. [Epub ahead of print]


Quantitative ligand and receptor binding studies reveal the mechanism of interleukin-36 (IL-36) pathway activation.

Zhou L, Todorovic V, Kakavas S, Sielaff B, Medina L, Wang L, Sadhukhan R, Stockmann H, Richardson PL, DiGiammarino E, Sun C, Scott V.

J Biol Chem. 2018 Jan 12;293(2):403-411. doi: 10.1074/jbc.M117.805739. Epub 2017 Nov 27.


Application of prognostic scores in the STOPAH trial: Discriminant function is no longer the optimal scoring system in alcoholic hepatitis.

Forrest EH, Atkinson SR, Richardson P, Masson S, Ryder S, Thursz MR, Allison M; STOPAH trial Management Group.

J Hepatol. 2018 Mar;68(3):511-518. doi: 10.1016/j.jhep.2017.11.017. Epub 2017 Nov 21.


Lenalidomide in combination or alone as maintenance therapy following autologous stem cell transplant in patients with multiple myeloma: a review of options for and against.

Richardson PG, Holstein SA, Schlossman RL, Anderson KC, Attal M, McCarthy PL.

Expert Opin Pharmacother. 2017 Dec;18(18):1975-1985. doi: 10.1080/14656566.2017.1409207. Epub 2017 Dec 1. Review.


CD38 antibodies in multiple myeloma: back to the future.

van de Donk NWCJ, Richardson PG, Malavasi F.

Blood. 2018 Jan 4;131(1):13-29. doi: 10.1182/blood-2017-06-740944. Epub 2017 Nov 8. Review.


Temporal patterns of caffeine intake in the United States.

Martyn D, Lau A, Richardson P, Roberts A.

Food Chem Toxicol. 2018 Jan;111:71-83. doi: 10.1016/j.fct.2017.10.059. Epub 2017 Nov 7.


A phase 1 clinical trial evaluating marizomib, pomalidomide and low-dose dexamethasone in relapsed and refractory multiple myeloma (NPI-0052-107): final study results.

Spencer A, Harrison S, Zonder J, Badros A, Laubach J, Bergin K, Khot A, Zimmerman T, Chauhan D, Levin N, MacLaren A, Reich SD, Trikha M, Richardson P.

Br J Haematol. 2018 Jan;180(1):41-51. doi: 10.1111/bjh.14987. Epub 2017 Oct 26.


Cell-Surface Receptor-Ligand Interaction Analysis with Homogeneous Time-Resolved FRET and Metabolic Glycan Engineering: Application to Transmembrane and GPI-Anchored Receptors.

Stockmann H, Todorovic V, Richardson PL, Marin V, Scott V, Gerstein C, Lake M, Wang L, Sadhukhan R, Vasudevan A.

J Am Chem Soc. 2017 Nov 22;139(46):16822-16829. doi: 10.1021/jacs.7b09359. Epub 2017 Nov 9.


Brain Penetration of the ROS1/ALK Inhibitor Lorlatinib Confirmed by PET.

Collier TL, Maresca KP, Normandin MD, Richardson P, McCarthy TJ, Liang SH, Waterhouse RN, Vasdev N.

Mol Imaging. 2017 Jan-Dec;16:1536012117736669. doi: 10.1177/1536012117736669.


The impact of rifaximin-α on the hospital resource use associated with the management of patients with hepatic encephalopathy: a retrospective observational study (IMPRESS).

Hudson M, Radwan A, Di Maggio P, Cipelli R, Ryder SD, Dillon JF, Cash WJ, Przemioslo RT, Wright M, Shawcross DL, Jalan R, Saksena S, Allison M, Richardson P, Farrington E, Aspinall RJ.

Frontline Gastroenterol. 2017 Oct;8(4):243-251. doi: 10.1136/flgastro-2016-100792. Epub 2017 Apr 7.


Ixazomib significantly prolongs progression-free survival in high-risk relapsed/refractory myeloma patients.

Avet-Loiseau H, Bahlis NJ, Chng WJ, Masszi T, Viterbo L, Pour L, Ganly P, Palumbo A, Cavo M, Langer C, Pluta A, Nagler A, Kumar S, Ben-Yehuda D, Rajkumar SV, San-Miguel J, Berg D, Lin J, van de Velde H, Esseltine DL, di Bacco A, Moreau P, Richardson PG.

Blood. 2017 Dec 14;130(24):2610-2618. doi: 10.1182/blood-2017-06-791228. Epub 2017 Oct 20.


Realgar nanoparticles versus ATO arsenic compounds induce in vitro and in vivo activity against multiple myeloma.

Cholujova D, Bujnakova Z, Dutkova E, Hideshima T, Groen RW, Mitsiades CS, Richardson PG, Dorfman DM, Balaz P, Anderson KC, Jakubikova J.

Br J Haematol. 2017 Dec;179(5):756-771. doi: 10.1111/bjh.14974. Epub 2017 Oct 19.


Recurrent cardiotoxicity potentiated by the interaction of proteasome inhibitor and immunomodulatory therapy for the treatment of multiple myeloma.

Fradley MG, Groarke JD, Laubach J, Alsina M, Lenihan DJ, Cornell RF, Maglio M, Shain KH, Richardson PG, Moslehi J.

Br J Haematol. 2018 Jan;180(2):271-275. doi: 10.1111/bjh.14970. Epub 2017 Oct 19.


Melflufen - a peptidase-potentiated alkylating agent in clinical trials.

Wickström M, Nygren P, Larsson R, Harmenberg J, Lindberg J, Sjöberg P, Jerling M, Lehmann F, Richardson P, Anderson K, Chauhan D, Gullbo J.

Oncotarget. 2017 Jun 8;8(39):66641-66655. doi: 10.18632/oncotarget.18420. eCollection 2017 Sep 12. Review.


Quality Issues Identified During the Evaluation of Biosimilars by the European Medicines Agency's Committee for Medicinal Products for Human Use.

Cilia M, Ruiz S, Richardson P, Salmonson T, Serracino-Inglott A, Wirth F, Borg JJ.

AAPS PharmSciTech. 2018 Feb;19(2):489-511. doi: 10.1208/s12249-017-0892-0. Epub 2017 Oct 12.


Influence of Disease and Patient Characteristics on Daratumumab Exposure and Clinical Outcomes in Relapsed or Refractory Multiple Myeloma.

Yan X, Clemens PL, Puchalski T, Lonial S, Lokhorst H, Voorhees PM, Usmani S, Richardson PG, Plesner T, Liu K, Orlowski RZ, Losic N, Jansson R, Ahmadi T, Lantz K, Ruixo JJP, Zhou H, Xu XS.

Clin Pharmacokinet. 2017 Oct 5. doi: 10.1007/s40262-017-0598-1. [Epub ahead of print]


Systematic review: Baclofen dosing protocols for alcohol use disorders used in observational studies.

Thompson A, Owens L, Richardson P, Pirmohamed M.

Eur Neuropsychopharmacol. 2017 Nov;27(11):1077-1089. doi: 10.1016/j.euroneuro.2017.08.434. Epub 2017 Sep 20. Review.


Low-fat Dietary Pattern and Pancreatic Cancer Risk in the Women's Health Initiative Dietary Modification Randomized Controlled Trial.

Jiao L, Chen L, White DL, Tinker L, Chlebowski RT, Van Horn LV, Richardson P, Lane D, Sangi-Haghpeykar H, El-Serag HB.

J Natl Cancer Inst. 2018 Jan 1;110(1). doi: 10.1093/jnci/djx117.


Three-dimensional printing in contemporary fixed prosthodontics: A technique article.

Bukhari S, Goodacre BJ, AlHelal A, Kattadiyil MT, Richardson PM.

J Prosthet Dent. 2017 Sep 6. pii: S0022-3913(17)30500-0. doi: 10.1016/j.prosdent.2017.07.008. [Epub ahead of print]


Treatment-free interval as a metric of patient experience and a health outcome of value for advanced multiple myeloma: the case for the histone deacetylase inhibitor panobinostat, a next-generation novel agent.

Richardson P, Roy A, Acharyya S, Panneerselvam A, Mendelson E, Günther A, Lonial S, Einsele H.

Expert Rev Hematol. 2017 Oct;10(10):933-939. doi: 10.1080/17474086.2017.1369399. Epub 2017 Sep 25.


Introducing an AT Passport: A Key to Managing Transitions Across the Lifespan.

Long S, Banes D, O'Donnell J, Richardson P.

Stud Health Technol Inform. 2017;242:76-79.


Role of Age and Race in the Risk of Hepatocellular Carcinoma in Veterans With Hepatitis B Virus Infection.

Mittal S, Kramer JR, Omino R, Chayanupatkul M, Richardson PA, El-Serag HB, Kanwal F.

Clin Gastroenterol Hepatol. 2018 Feb;16(2):252-259. doi: 10.1016/j.cgh.2017.08.042. Epub 2017 Sep 1.


New developments in the management of relapsed/refractory multiple myeloma - the role of ixazomib.

Richardson PG, Kumar S, Laubach JP, Paba-Prada C, Gupta N, Berg D, van de Velde H, Moreau P.

J Blood Med. 2017 Aug 22;8:107-121. doi: 10.2147/JBM.S102328. eCollection 2017. Review.


IgA multiple myeloma in a patient with an IgG pemphigus foliaceus-like exanthem.

Lee N, Lockwood SJ, Richardson P, Paba-Prada C, Saavedra AP.

Int J Dermatol. 2017 Oct;56(10):1058-1060. doi: 10.1111/ijd.13721. Epub 2017 Aug 30. No abstract available.


Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Women: A Phase 2 Randomized Trial.

Gulick RM, Wilkin TJ, Chen YQ, Landovitz RJ, Amico KR, Young AM, Richardson P, Marzinke MA, Hendrix CW, Eshleman SH, McGowan I, Cottle LM, Andrade A, Marcus C, Klingman KL, Chege W, Rinehart AR, Rooney JF, Andrew P, Salata RA, Siegel M, Manabe YC, Frank I, Ho K, Santana J, Stekler JD, Swaminathan S, McCauley M, Hodder S, Mayer KH.

Ann Intern Med. 2017 Sep 19;167(6):384-393. doi: 10.7326/M17-0520. Epub 2017 Aug 22.


Updated analysis of CALGB (Alliance) 100104 assessing lenalidomide versus placebo maintenance after single autologous stem-cell transplantation for multiple myeloma: a randomised, double-blind, phase 3 trial.

Holstein SA, Jung SH, Richardson PG, Hofmeister CC, Hurd DD, Hassoun H, Giralt S, Stadtmauer EA, Weisdorf DJ, Vij R, Moreb JS, Callander NS, van Besien K, Gentile TG, Isola L, Maziarz RT, Bashey A, Landau H, Martin T, Qazilbash MH, Rodriguez C, McClune B, Schlossman RL, Smith SE, Hars V, Owzar K, Jiang C, Boyd M, Schultz C, Wilson M, Hari P, Pasquini MC, Horowitz MM, Shea TC, Devine SM, Linker C, Anderson KC, McCarthy PL.

Lancet Haematol. 2017 Sep;4(9):e431-e442. doi: 10.1016/S2352-3026(17)30140-0. Epub 2017 Aug 17.


Defibrotide for children and adults with hepatic veno-occlusive disease post hematopoietic cell transplantation.

Corbacioglu S, Richardson PG.

Expert Rev Gastroenterol Hepatol. 2017 Oct;11(10):885-898. doi: 10.1080/17474124.2017.1370372. Epub 2017 Sep 4.


Dose and Schedule Selection of the Oral Proteasome Inhibitor Ixazomib in Relapsed/Refractory Multiple Myeloma: Clinical and Model-Based Analyses.

Gupta N, Yang H, Hanley MJ, Zhang S, Liu R, Kumar S, Richardson PG, Skacel T, Venkatakrishnan K.

Target Oncol. 2017 Oct;12(5):643-654. doi: 10.1007/s11523-017-0524-3.


Response to DAA therapy in the NHS England Early Access Programme for rare HCV subtypes from low and middle income countries.

da Silva Filipe A, Sreenu V, Hughes J, Aranday-Cortes E, Irving WL, Foster GR, Agarwal K, Rosenberg W, Macdonald D, Richardson P, Aldersley MA, Wiselka M, Ustianowski A, McLauchlan J, Thomson EC.

J Hepatol. 2017 Dec;67(6):1348-1350. doi: 10.1016/j.jhep.2017.06.035. Epub 2017 Aug 5. No abstract available.


Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation.

Corbacioglu S, Carreras E, Ansari M, Balduzzi A, Cesaro S, Dalle JH, Dignan F, Gibson B, Guengoer T, Gruhn B, Lankester A, Locatelli F, Pagliuca A, Peters C, Richardson PG, Schulz AS, Sedlacek P, Stein J, Sykora KW, Toporski J, Trigoso E, Vetteranta K, Wachowiak J, Wallhult E, Wynn R, Yaniv I, Yesilipek A, Mohty M, Bader P.

Bone Marrow Transplant. 2018 Feb;53(2):138-145. doi: 10.1038/bmt.2017.161. Epub 2017 Jul 31.


A prospective cohort study examining the effectiveness of baclofen in the maintenance of abstinence in alcohol use disorder patients attending a joint liver and alcohol treatment clinic.

Owens L, Thompson A, Rose A, Gilmore I, Pirmohamed M, Richardson P.

Alcohol. 2017 Aug;62:11-15. doi: 10.1016/j.alcohol.2016.12.005. Epub 2017 May 15.


Consensus Report by Pediatric Acute Lung Injury and Sepsis Investigators and Pediatric Blood and Marrow Transplantation Consortium Joint Working Committees: Supportive Care Guidelines for Management of Veno-Occlusive Disease in Children and Adolescents, Part 1: Focus on Investigations, Prophylaxis, and Specific Treatment.

Bajwa RPS, Mahadeo KM, Taragin BH, Dvorak CC, McArthur J, Jeyapalan A, Duncan CN, Tamburro R, Gehred A, Lehmann L, Richardson P, Auletta JJ, Woolfrey AE.

Biol Blood Marrow Transplant. 2017 Nov;23(11):1817-1825. doi: 10.1016/j.bbmt.2017.07.021. Epub 2017 Jul 25. Review.


Supplemental Content

Loading ...
Support Center